» Articles » PMID: 19228977

Restricted Cortical and Amygdaloid Removal of Vesicular Glutamate Transporter 2 in Preadolescent Mice Impacts Dopaminergic Activity and Neuronal Circuitry of Higher Brain Function

Abstract

A major challenge in neuroscience is to resolve the connection between gene functionality, neuronal circuits, and behavior. Most, if not all, neuronal circuits of the adult brain contain a glutamatergic component, the nature of which has been difficult to assess because of the vast cellular abundance of glutamate. In this study, we wanted to determine the role of a restricted subpopulation of glutamatergic neurons within the forebrain, the Vglut2-expressing neurons, in neuronal circuitry of higher brain function. Vglut2 expression was selectively deleted in the cortex, hippocampus, and amygdala of preadolescent mice, which resulted in increased locomotor activity, altered social dominance and risk assessment, decreased sensorimotor gating, and impaired long-term spatial memory. Presynaptic VGLUT2-positive terminals were lost in the cortex, striatum, nucleus accumbens, and hippocampus, and a downstream effect on dopamine binding site availability in the striatum was evident. A connection between the induced late-onset, chronic reduction of glutamatergic neurotransmission and dopamine signaling within the circuitry was further substantiated by a partial attenuation of the deficits in sensorimotor gating by the dopamine-stabilizing antipsychotic drug aripiprazole and an increased sensitivity to amphetamine. Somewhat surprisingly, given the restricted expression of Vglut2 in regions responsible for higher brain function, our analyses show that VGLUT2-mediated neurotransmission is required for certain aspects of cognitive, emotional, and social behavior. The present study provides support for the existence of a neurocircuitry that connects changes in VGLUT2-mediated neurotransmission to alterations in the dopaminergic system with schizophrenia-like behavioral deficits as a major outcome.

Citing Articles

Vesicular glutamate transporter 2 expression in the ventral tegmental area of outbred male rats following exposure to nicotine and alcohol.

Vrettou M, Thalhammer S, Svensson A, Dumas S, Nilsson K, Wallen-Mackenzie A Drug Alcohol Depend Rep. 2023; 8:100180.

PMID: 37533815 PMC: 10391930. DOI: 10.1016/j.dadr.2023.100180.


Behavioral profiling of SLC38A10 knockout mice using the multivariate concentric square field test.

Lindberg F, Roman E, Fredriksson R Front Behav Neurosci. 2023; 16:987037.

PMID: 36620864 PMC: 9815452. DOI: 10.3389/fnbeh.2022.987037.


Activation of the anterior cingulate cortex ameliorates anxiety in a preclinical model of fetal alcohol spectrum disorders.

Hwang H, Hashimoto-Torii K Transl Psychiatry. 2022; 12(1):24.

PMID: 35058425 PMC: 8776849. DOI: 10.1038/s41398-022-01789-1.


14-3-3 mitigates alpha-synuclein aggregation and toxicity in the in vivo preformed fibril model.

Underwood R, Gannon M, Pathak A, Kapa N, Chandra S, Klop A Acta Neuropathol Commun. 2021; 9(1):13.

PMID: 33413679 PMC: 7792107. DOI: 10.1186/s40478-020-01110-5.


Potentiation of Divergent Medial Amygdala Pathways Drives Experience-Dependent Aggression Escalation.

Nordman J, Ma X, Gu Q, Potegal M, Li H, Kravitz A J Neurosci. 2020; 40(25):4858-4880.

PMID: 32424020 PMC: 7326350. DOI: 10.1523/JNEUROSCI.0370-20.2020.


References
1.
Tamminga C, Holcomb H . Phenotype of schizophrenia: a review and formulation. Mol Psychiatry. 2004; 10(1):27-39. DOI: 10.1038/sj.mp.4001563. View

2.
Gras C, Herzog E, Carlo Bellenchi G, Bernard V, Ravassard P, Pohl M . A third vesicular glutamate transporter expressed by cholinergic and serotoninergic neurons. J Neurosci. 2002; 22(13):5442-51. PMC: 6758212. View

3.
LUBY E, Cohen B, Rosenbaum G, GOTTLIEB J, Kelley R . Study of a new schizophrenomimetic drug; sernyl. AMA Arch Neurol Psychiatry. 1959; 81(3):363-9. DOI: 10.1001/archneurpsyc.1959.02340150095011. View

4.
Varoqui H, Schafer M, Zhu H, Weihe E, Erickson J . Identification of the differentiation-associated Na+/PI transporter as a novel vesicular glutamate transporter expressed in a distinct set of glutamatergic synapses. J Neurosci. 2002; 22(1):142-55. PMC: 6757588. View

5.
Sesack S, Carr D, Omelchenko N, Pinto A . Anatomical substrates for glutamate-dopamine interactions: evidence for specificity of connections and extrasynaptic actions. Ann N Y Acad Sci. 2003; 1003:36-52. DOI: 10.1196/annals.1300.066. View